Key facts
- Small Machines’s last known valuation is $10.9M (Jul 2020).
- It has raised $3.4M; the latest was Later Stage VC ($5.0M) in Jun 2025.
- Notable investors include Tech Incubator Program for Startup, Korea Technology Finance, Hanwha Investment & Securities Company, Korea Science & Technology Holdings, Mplus (Korea) — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Small Machines
- ·The full record, as it builds
Funding rounds
No funding rounds for Small Machines are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Small Machines
Developer of a medical diagnostic system designed for point-of-care testing. The company's system integrates microfluidics, biosensing, and artificial intelligence to deliver lab-grade diagnostic results in real-time, featuring automated cell analysis, multiplex immunoassays, and hematology testing, enabling healthcare providers, emergency rooms, and research institutions to conduct rapid and precise disease detection while improving accessibility to high-performance diagnostics in both clinical and remote environments.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2014
- Employees
- 28
- Website
- smallmachines.co.kr/
- Ownership
- Privately Held (backing)
Small Machines doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Small Machines shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Small Machines in its N-PORT filings yet. We sweep new filings monthly.